Go Pro
→ The retirement stock I'd buy before Nvidia today (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$104.91
$103.67
$38.81
▼
$104.98
$20.03B1.413.55 million shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
0.00%0.00%0.00%0.00%+129.66%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$104.91
$103.67
$38.81
▼
$104.98
$20.03B1.413.55 million shsN/A
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
0.00%0.00%0.00%0.00%+129.66%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
1.95
Reduce$98.21-6.38% Downside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$3.25B6.17$1.27 per share82.83$12.58 per share8.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
-$207.95M-$1.10N/A209.822.02-6.40%0.53%0.22%N/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
0.97
2.43
2.17

Institutional Ownership

CompanyInstitutional Ownership
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
88.82%

Insider Ownership

CompanyInsider Ownership
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
1.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
7,200190.89 million188.60 millionOptionable

Recent News About These Companies

Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag
April 16, 2026  |  proactiveinvestors.comhttps://www.proactiveinvestors.com/companies/news/1090692?snapi
Banque Pictet & Cie SA Lowers Position in Exact Sciences Corporation $EXAS
April 3, 2026  |  defenseworld.netD
Exact Sciences Corporation
March 26, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/EXAS
Abbott (ABT) Finalizes $21 Billion Exact Sciences (EXAS) Takeover
March 24, 2026  |  blockonomi.comhttps://blockonomi.com/abbott-abt-finalizes-21-billion-exact-sciences-exas-takeover/
Abbott closes $23 billion deal to buy Madison-based Exact Sciences
March 24, 2026  |  jsonline.comJ
Abbott completes acquisition of Exact Sciences
March 23, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/abbott-completes-acquisition-exact-sciences-125000111.html
How Walgreens’ Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story
March 22, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/walgreens-pharmacy-led-cologuard-expansion-041556121.html
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds
March 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/1-mid-cap-stock-consider-191230410.html
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
March 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/exact-sciences-present-molecular-residual-203100978.html
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
March 17, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260317158639/en/Exact-Sciences-to-Present-New-Molecular-Residual-Disease-and-Multi-Cancer-Early-Detection-Data-at-AACR-2026/
Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard® Tests to Expand Reach
March 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/workflow-services-supports-walgreens-national-043900315.html
Exact Sciences (EXAS) is a Top-Ranked Momentum Stock: Should You Buy?
March 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2882308/exact-sciences-exas-is-a-top-ranked-momentum-stock-should-you-buy?cid=cs-stocknewsapi-ft-tale_of_the_tape|zacks_education_momentum_score-2882308
Exact Sciences Corp.
March 10, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/exas/company-people?gaa_n=AWEtsqfwxO2uAhhncfE_udf9dxbIrbld21FsGfLwNRP0-DcwkPUyYzoM6wik&gaa_ts=69b0b7b1
Exact Sciences Case Study Links Higher Screening Rates With Undervalued Shares
March 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/exact-sciences-case-study-links-050833218.html
3 Cash-Producing Stocks We Approach with Caution
March 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/3-cash-producing-stocks-approach-121937046.html
Cancer tests are becoming more precise and guiding pharma R&D
March 6, 2026  |  pharmavoice.comP
Is Exact Sciences (EXAS) Pricing Reflect Long Term Cancer Screening Growth Potential
March 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/exact-sciences-exas-pricing-reflect-171310992.html
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
March 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/exact-sciences-named-gallup-exceptional-140000173.html
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
March 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/cslly-exas-better-value-stock-164002500.html
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
March 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2878844/cslly-or-exas-which-is-the-better-value-stock-right-now?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_3-2878844

New MarketBeat Followers Over Time

Top Headlines

View All Headlines
Stack of office folders stamped “UPGRADED,” symbolizing rising analyst ratings for stocks like Micron in 2026.
These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
By Leo Miller | August 10, 2026
Green upward arrow between two coin stacks on a desk, with a computer monitor showing financial charts in the background.
A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
By Nathan Reiff | July 22, 2026
Riot Platforms logo overlaid on an aerial view of a large data center facility with adjacent electrical substation.
Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
By Jeffrey Neal Johnson | August 13, 2026
Hut 8 logo with a glowing blue starburst symbol and orange company name on a textured gray background.
Texas Power Play: Hut 8 Sparks a $9.8B AI Infrastructure Deal
By Jeffrey Neal Johnson | July 22, 2026
A steak cooks over an open flame on a restaurant grill, with kitchen equipment visible in the background.
Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
By Dan Schmidt | August 15, 2026
Exact Sciences stock logo

Exact Sciences NASDAQ:EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas